Pancreatic islets quality and potency cannot be verified as required for drugs: Reflection on the FDA review of a biological license application for human islets

Islets for US Collaborative; Cell Transplantation Committee of the American Society of Transplant Surgeons (ASTS)

doi:10.1097/TP.0000000000003880

Pancreatic islets quality and potency cannot be verified as required for drugs: Reflection on the FDA review of a biological license application for human islets

Islets for US Collaborative, Cell Transplantation Committee of the American Society of Transplant Surgeons (ASTS)

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	E409-E410
Journal	Transplantation
Volume	105
Issue number	12
DOIs	https://doi.org/10.1097/TP.0000000000003880
State	Published - Dec 1 2021
Externally published	Yes

ASJC Scopus subject areas

Transplantation

Access to Document

10.1097/TP.0000000000003880

Cite this

Pancreatic islets quality and potency cannot be verified as required for drugs: Reflection on the FDA review of a biological license application for human islets. / Islets for US Collaborative; Cell Transplantation Committee of the American Society of Transplant Surgeons (ASTS).
In: Transplantation, Vol. 105, No. 12, 01.12.2021, p. E409-E410.

Research output: Contribution to journal › Letter › peer-review

Islets for US Collaborative & Cell Transplantation Committee of the American Society of Transplant Surgeons (ASTS) 2021, 'Pancreatic islets quality and potency cannot be verified as required for drugs: Reflection on the FDA review of a biological license application for human islets', Transplantation, vol. 105, no. 12, pp. E409-E410. https://doi.org/10.1097/TP.0000000000003880

@article{2e796ee15baf4b3287ed3405a5130698,

title = "Pancreatic islets quality and potency cannot be verified as required for drugs: Reflection on the FDA review of a biological license application for human islets",

author = "{Islets for US Collaborative} and {Cell Transplantation Committee of the American Society of Transplant Surgeons (ASTS)} and Piotr Witkowski and Roi Anteby and Olaitan, {Oyedolamu K.} and Forbes, {Racheal C.} and Silke Niederhaus and Camilo Ricordi and Fair, {Jeffrey H.} and Harland, {Robert C.}",

year = "2021",

month = dec,

day = "1",

doi = "10.1097/TP.0000000000003880",

language = "English (US)",

volume = "105",

pages = "E409--E410",

journal = "Transplantation",

issn = "0041-1337",

publisher = "Lippincott Williams and Wilkins",

number = "12",

}

TY - JOUR

T1 - Pancreatic islets quality and potency cannot be verified as required for drugs

T2 - Reflection on the FDA review of a biological license application for human islets

AU - Islets for US Collaborative

AU - Cell Transplantation Committee of the American Society of Transplant Surgeons (ASTS)

AU - Witkowski, Piotr

AU - Anteby, Roi

AU - Olaitan, Oyedolamu K.

AU - Forbes, Racheal C.

AU - Niederhaus, Silke

AU - Ricordi, Camilo

AU - Fair, Jeffrey H.

AU - Harland, Robert C.

PY - 2021/12/1

Y1 - 2021/12/1

UR - http://www.scopus.com/inward/record.url?scp=85120715328&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85120715328&partnerID=8YFLogxK

U2 - 10.1097/TP.0000000000003880

DO - 10.1097/TP.0000000000003880

M3 - Letter

C2 - 34231527

AN - SCOPUS:85120715328

SN - 0041-1337

VL - 105

SP - E409-E410

JO - Transplantation

JF - Transplantation

IS - 12

ER -

Pancreatic islets quality and potency cannot be verified as required for drugs: Reflection on the FDA review of a biological license application for human islets

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this